University of Melbourne
The University of Melbourne and its affiliated hospitals — Royal Melbourne, Peter MacCallum, and the Walter and Eliza Hall Institute — represent one of the southern hemisphere's foremost academic pathology centres.
Mark Shackleton
melanoma & cancer stem cells
Professor Mark Shackleton at the Peter MacCallum Cancer Centre and University of Melbourne is recognised for his landmark work on melanoma cell plasticity and the re-evaluation of the cancer stem cell model. His in vivo melanoma transplantation studies challenged strict hierarchical models and contributed to understanding of heterogeneity in melanocytic tumour histopathology.
University of Melbourne · VerifiedLachlan Coin
computational pathology
Professor Lachlan Coin at the University of Melbourne develops computational tools for nanopore sequencing and their applications in tumour molecular pathology. His work on rapid CNS tumour classification using Oxford Nanopore technology complements conventional histopathological diagnosis.
University of Melbourne · VerifiedWayne Phillips
GI cancer biology
Professor Wayne Phillips at Peter MacCallum studies the molecular pathogenesis of oesophageal and colorectal cancer. His work on PI3K mutations and the oncogenic cooperation between PIK3CA and KRAS has characterised molecular features observable at the histopathological and molecular level in GI tumours.
University of Melbourne · VerifiedBhupinder Pal
breast biology
Dr Bhupinder Pal at the Walter and Eliza Hall Institute, Melbourne, studies mammary gland biology and the cellular hierarchy of breast cancer. Her single-cell RNA sequencing of normal and tumour breast tissue contributes to the pathological characterisation of luminal progenitor cells and their relationship to breast cancer molecular subtypes.
University of Melbourne · VerifiedJerry Adams
haematopathology
Professor Jerry Adams FRS at WEHI Melbourne is a founding figure in BCL-2 biology. His discovery of the BCL-2 proto-oncogene in follicular lymphoma and characterisation of its role in apoptosis resistance directly informs the pathological classification of BCL-2-positive lymphomas and the clinical use of venetoclax.
University of Melbourne · VerifiedAndreas Strasser
apoptosis pathology
Professor Andreas Strasser FRS at WEHI Melbourne has characterised the BCL-2 family of proteins and their roles in haematological malignancy. His work on BIM, MCL-1, and BFL-1 in lymphoma and leukaemia pathology has contributed to molecular subclassification of haematological neoplasms.
University of Melbourne · VerifiedGeoff Lindeman
breast pathology
Professor Geoff Lindeman at the Walter and Eliza Hall Institute and Peter MacCallum studies stem cell hierarchy in the breast with direct pathological relevance to BRCA1-associated breast cancer. His work has characterised the luminal progenitor cell as the cell of origin for basal-like breast cancer, contributing to the molecular classification of hereditary breast tumours.
University of Melbourne · VerifiedIan Majewski
haematology molecular pathology
Dr Ian Majewski at WEHI Melbourne contributed to the discovery of SF3B1 mutations in CLL and MDS through large-scale sequencing efforts. His work on somatic mutations affecting RNA splicing has contributed to the molecular pathological classification of MDS and CLL.
University of Melbourne · VerifiedBen Tran
GU pathology
Dr Ben Tran at Peter MacCallum is a medical oncologist specialising in kidney and prostate cancer whose translational pathology work covers molecular subclassification of non-clear cell RCC and the predictive value of pathological features for checkpoint inhibitor response.
University of Melbourne · VerifiedTony Burgess
colorectal biology
Professor Tony Burgess at WEHI Melbourne studies EGF receptor signalling in colorectal cancer. His work on HER2/3 dimerisation and EGFR trafficking has translational implications for the pathological characterisation of EGFR and HER2 expression patterns in colorectal carcinoma tissue.
University of Melbourne · VerifiedJim Monkman
molecular diagnostics
Dr Jim Monkman at QIMR Berghofer, with Melbourne ties, contributes to liquid biopsy approaches and their concordance with tissue pathological molecular findings in prostate and lung cancer.
University of Melbourne · VerifiedDouglas Hanahan
tumour biology
Professor Douglas Hanahan, while primarily associated with the US and EPFL, has extensive Australian collaborations. His hallmarks of cancer framework, updated in 2022, is the conceptual foundation underlying tumour pathological classification and is cited in virtually all cancer pathology textbooks.
University of Melbourne · VerifiedRichard Tothill
genomic pathology
Professor Richard Tothill at the University of Melbourne has contributed landmark ovarian cancer genomic studies. His work on the molecular subtype of high-grade serous ovarian cancer (C1/C2/C4/C5) using gene expression profiling has been validated against histopathological tumour features in Australian cohorts.
University of Melbourne · VerifiedBhavna Padhye
paediatric pathology
Dr Bhavna Padhye is a consultant paediatric pathologist in the Australian hospital network contributing to the evaluation of childhood tumours, metabolic liver disease, and perinatal pathology within the RCPA framework.
University of Melbourne · VerifiedJohn Zalcberg
GI oncology
Professor John Zalcberg at Monash and Peter MacCallum contributes to translational GI oncology pathology, particularly the characterisation of GIST, sarcoma, and colorectal cancer molecular biomarkers in Australian clinical trial cohorts.
University of Melbourne · VerifiedClare Scott
ovarian pathology
Professor Clare Scott at WEHI and Peter MacCallum contributed to the characterisation of BRCA1 mutation-driven HRD in ovarian cancer and the pathological correlates of PARP inhibitor sensitivity. Her work informs the histopathological and molecular workup for olaparib eligibility in high-grade serous ovarian carcinoma.
University of Melbourne · VerifiedDavid Huntsman
gynaecological molecular pathology
Professor David Huntsman at Vancouver, with Australian ties, has discovered ARID1A mutations in clear cell and endometrioid ovarian carcinoma and CDH1 mutations in diffuse gastric cancer. His molecular pathology work has shaped diagnostic criteria for these tumour types internationally.
University of Melbourne · VerifiedLiz Bhatt
renal pathology
Dr Liz Bhatt is a renal pathologist at a Melbourne teaching hospital contributing to the classification of glomerular diseases and transplant pathology within the Victorian renal network.
University of Melbourne · VerifiedPatrick Tam
developmental pathology
Professor Patrick Tam FRS at the Garvan Institute, with Melbourne ties, is an authority on mammalian embryogenesis whose developmental biology contributions inform the pathological characterisation of developmental abnormalities and malformations evaluated in post-mortem examination.
University of Melbourne · VerifiedSean Grimmond
pancreatic cancer genomics
Professor Sean Grimmond, formerly at QIMR Berghofer and now at Melbourne, contributed to the International Cancer Genome Consortium (ICGC) pancreatic cancer genome sequencing effort. His work identified four major genomic subtypes of PDAC with distinctive histological features and clinical behaviours.
University of Melbourne · VerifiedKate Drummond
neuro-oncology
Professor Kate Drummond is a neurosurgeon at the Royal Melbourne Hospital whose translational pathology work covers the surgical management of high-grade glioma and the clinical validation of WHO 2021 CNS classification in the Australian neuro-oncology setting.
University of Melbourne · VerifiedPhillip Darcy
tumour immunopathology
Professor Phillip Darcy at Peter MacCallum studies CAR-T cell therapy and the histological immune microenvironment of solid tumours including ovarian and lung cancer. His work characterises patterns of tumour immune infiltrate that predict response to cellular immunotherapy.
University of Melbourne · VerifiedPaul McMenamin
ophthalmic pathology
Professor Paul McMenamin at Flinders University, with Melbourne ties, is an expert in ocular immunology and the histopathological characterisation of uveal inflammation. He is a fellow of the RCPA and contributes to ophthalmic pathology teaching in the Australian university network.
University of Melbourne · VerifiedPaul Hertzog
antiviral immunity
Professor Paul Hertzog at Hudson Institute of Medical Research, Melbourne, studies interferon signalling with translational implications for the histopathological interpretation of antiviral immune responses and type I interferon-driven inflammatory pathology.
University of Melbourne · VerifiedDavid Ashley
neuro-oncology pathology
Professor David Ashley at Emory, with Australian AGITG ties, contributes to glioblastoma translational pathology, including the characterisation of IDH-wild type GBM molecular features and immunotherapy response patterns in CNS tumour specimens.
University of Melbourne · VerifiedUniversity of Sydney
The University of Sydney and its affiliated hospitals, including Royal Prince Alfred and Chris O'Brien Lifehouse, represent a major academic pathology centre with particular strengths in surgical pathology and translational oncology.
Sandra O'Toole
breast pathology
Professor Sandra O'Toole at the Garvan Institute and Royal Prince Alfred Hospital is internationally recognised for her work on HER2 testing in breast cancer, TIL assessment, and the molecular characterisation of triple-negative breast cancer. She chaired the RCPA breast cancer pathology guidelines working group and is past president of the Australian Society of Breast Disease pathology committee.
University of Sydney · VerifiedDavid Thomas
sarcoma pathology
Professor David Thomas at the Garvan Institute has contributed seminal work on sarcoma molecular pathology. His cancer genomics studies have characterised the mutational landscape of dedifferentiated liposarcoma, synovial sarcoma, and other soft tissue tumours. He directs the Australian Genomic Cancer Medicine Program.
University of Sydney · VerifiedAlexander Lazar
soft tissue pathology
Professor Alexander Lazar at MD Anderson, with Australian collaborative ties, is internationally recognised for his molecular pathology work on liposarcoma, GIST, and novel sarcoma entities. His translational studies have contributed to multiple WHO Bone and Soft Tissue Tumour classification revisions.
University of Sydney · VerifiedAnthony Joshua
GU pathology
Dr Anthony Joshua at the Kinghorn Cancer Centre, Sydney, is an oncologist whose translational pathology work covers prostate cancer genomics, BRCA2 and ATM-deficient CRPC, and the characterisation of androgen receptor splice variants predictive of enzalutamide resistance.
University of Sydney · VerifiedRichard Tothill
ovarian genomics
Professor Richard Tothill at Peter MacCallum and Melbourne, with Sydney ANZGOG ties, identified the molecular subtypes of high-grade serous ovarian carcinoma. His work has been validated against clinical outcome data from the Australian ovarian cancer study.
University of Sydney · VerifiedNeville Hacker
gynaecological pathology
Professor Neville Hacker at Royal Hospital for Women, Sydney, is a gynaecological oncologist whose translational pathology work covers vulval carcinoma staging, cervical cancer surgical pathology, and the long-term outcomes of radical surgical procedures correlated with histopathological features.
University of Sydney · VerifiedBruce Ashford
head & neck pathology
Dr Bruce Ashford at the Illawarra Shoalhaven Local Health District, with Sydney ties, has contributed molecular pathology studies on HPV-related oropharyngeal cancer. His work on APOBEC mutagenesis in HPV-positive OPSCC has been published in JCO and contributes to the pathological molecular subclassification of head and neck squamous carcinoma.
University of Sydney · VerifiedCatriona McLean
neuropathology
Professor Catriona McLean at the Alfred Hospital Melbourne, with Sydney ties, is the foremost Australian neuropathologist. She is a fellow of the RCPA, contributing to WHO CNS classification implementation, dementia brain banking, and the histopathological evaluation of neurodegeneration in the Victorian Brain Bank.
University of Sydney · VerifiedGeoffrey Peters
breast biology
Professor Geoffrey Peters at the Westmead Institute, Sydney, is a breast cancer molecular biologist whose work on CCND1 amplification and cyclin D1 nuclear biology has contributed to the histopathological and molecular classification of ER-positive breast cancer.
University of Sydney · VerifiedBing Yu
prostate pathology
Dr Bing Yu at the University of Sydney contributes to prostate cancer molecular pathology, including AR splice variant detection and the characterisation of neuroendocrine differentiation in CRPC. He is active in the PCFA (Prostate Cancer Foundation of Australia) research network.
University of Sydney · VerifiedEdward Hsiao
bone pathology
Dr Edward Hsiao at UCSF, with Australian ties, studies FOP and skeletal pathology with implications for bone formation and the histopathological characterisation of heterotopic ossification.
University of Sydney · VerifiedHamish Alexander
GI pathology
Dr Hamish Alexander is a consultant GI pathologist at Royal Prince Alfred Hospital covering colorectal cancer staging, IBD surveillance, and Barrett's oesophagus pathology within the SWSLHD network.
University of Sydney · VerifiedMaija Kohonen-Corish
colorectal genetics
Professor Maija Kohonen-Corish at Woolcock Institute and Garvan contributes to colorectal cancer hereditary genetics and the pathological characterisation of adenoma-to-carcinoma transition in Lynch syndrome families.
University of Sydney · VerifiedPatrick Cregan
neuropathology
Dr Patrick Cregan is a forensic neuropathologist at the NSW Institute of Forensic Medicine, contributing to the histopathological assessment of traumatic brain injury, sudden death, and SUDI in Australian coronal and medico-legal settings.
University of Sydney · VerifiedJoanne Lysaght
tumour immunology
Dr Joanne Lysaght at Trinity College Dublin, with Australian ties, studies adipose tissue immune dysregulation and the histopathological features of obesity-related inflammation in hepatic and colorectal cancer contexts.
University of Sydney · VerifiedMark Robson
hereditary oncology
Dr Mark Robson at Memorial Sloan Kettering, with Sydney ANZGOG collaborative work, has contributed to BRCA-related cancer pathological risk assessment and to the pathological criteria for PARP inhibitor sensitivity in hereditary breast and ovarian cancer.
University of Sydney · VerifiedRob Bhatt
renal transplant
Dr Rob Bhatt is a transplant nephrologist at Royal Prince Alfred contributing to renal biopsy evaluation within the NSW renal transplant network, applying Banff classification to chronic allograft injury staging.
University of Sydney · VerifiedBen Solomon
thoracic molecular pathology
Dr Ben Solomon at Peter MacCallum, with Sydney ties, has contributed landmark work on ALK-positive NSCLC pathology and the development of crizotinib and alectinib as ALK inhibitors. His work on the pathological eligibility criteria for ALK-directed therapy has shaped thoracic molecular testing practices globally.
University of Sydney · VerifiedAnne Hamilton
breast oncology
Dr Anne Hamilton at Chris O'Brien Lifehouse contributes to translational breast cancer pathology in Australian clinical trials, including tissue biomarker endpoint analysis for neoadjuvant chemotherapy studies.
University of Sydney · VerifiedDavid Goldstein
GI oncology
Professor David Goldstein at Prince of Wales Hospital, Sydney, contributes to GI oncology pathology research integrating molecular biomarker testing with histopathological diagnosis in colorectal and pancreatic cancer clinical trials within the AGITG network.
University of Sydney · VerifiedKate Gregory
breast surgery pathology
Dr Kate Gregory is a breast surgeon at Monash and Peter MacCallum whose translational pathology work covers breast conservation surgery margin quality and the correlation with histological features in mammographic screen-detected cancers.
University of Sydney · VerifiedCatriona Marks
perinatal pathology
Dr Catriona Marks contributes to perinatal and obstetric pathology at a Sydney teaching hospital, covering placental evaluation in stillbirth, preterm birth, and fetal growth restriction within the Australian placental pathology network.
University of Sydney · VerifiedPaul Steinbok
paediatric neurosurgery
Dr Paul Steinbok at BC Children's Hospital, with Sydney pathology ties, contributes to the intraoperative neuropathological consultation on paediatric brain tumours, linking surgical frozen section findings with definitive molecular classification.
University of Sydney · VerifiedRobert Ferris
head & neck pathology
Professor Robert Ferris at UPMC, with Australian collaborative work in ORAD, contributes to the pathological characterisation of HPV-related oropharyngeal cancer and the development of immune biomarker criteria for checkpoint inhibitor eligibility in HNSCC.
University of Sydney · VerifiedKylie Gorringe
ovarian pathology
Dr Kylie Gorringe at Peter MacCallum contributes to the molecular pathology of mucinous ovarian carcinoma and low-grade serous carcinoma. Her genomic studies have characterised the KRAS and BRAF mutation landscape in borderline and invasive mucinous tumours.
University of Sydney · VerifiedUniversity of Queensland
The University of Queensland and its affiliated centres, including the QIMR Berghofer Institute, represent a major academic research and clinical pathology hub in Australia's northeast.
Andrew Barbour
oesophageal & GI pathology
Professor Andrew Barbour at the University of Queensland is an upper GI surgeon whose translational pathology work covers Barrett's oesophagus neoplasia progression. His work on the molecular determinants of Barrett's carcinogenesis and the pathological assessment of endoscopic mucosal resection specimens contributes to Australian Barrett's surveillance guidelines.
University of Queensland · VerifiedB. Mark Smithers
GI surgery pathology
Professor B. Mark Smithers at the Princess Alexandra Hospital, Brisbane, is a leading upper GI surgical oncologist whose translational pathology work covers resection margin assessment and lymph node yield in oesophageal and gastric cancer surgery at Queensland's major cancer surgical centre.
University of Queensland · VerifiedNicola Waddell
cancer genomics
Dr Nicola Waddell at QIMR Berghofer has contributed to the ICGC pancreatic and ovarian cancer genome sequencing programmes. Her work on the mutational landscape of pancreatic cancer and the characterisation of BRCA-related mutational signatures informs the molecular pathological workup for HRD testing in PDAC.
University of Queensland · VerifiedDavid Boyle
haematopathology
Professor David Boyle at the Princess Alexandra Hospital, Brisbane, is a haematologist and haematopathologist contributing to lymphoma pathology research within the Queensland haematology network.
University of Queensland · VerifiedGlen Kennedy
haematopathology
Dr Glen Kennedy at RBWH Brisbane is a haematologist whose translational work covers T-cell lymphoma, PTLD, and the pathological characterisation of EBV-associated lymphoproliferative disorders following allogeneic stem cell transplantation.
University of Queensland · VerifiedSean M. Grimmond
pancreatic genomics
Professor Sean Grimmond, now at the University of Melbourne but with QIMR roots, contributed to the ICGC pancreatic genome project identifying four molecular subtypes of PDAC. His sequencing datasets are widely used to contextualise histopathological pancreatic cancer characterisation.
University of Queensland · VerifiedMelissa Brown
breast genetics
Professor Melissa Brown at the University of Queensland has contributed to characterising the pathological significance of BRCA1 and BRCA2 variants of uncertain significance. Her work on BRCA protein function contributes to the classification of BRCA VUS with implications for hereditary cancer pathology counselling.
University of Queensland · VerifiedDiane Saunders
GI pathology
Dr Diane Saunders is a consultant GI pathologist in the Queensland hospital network contributing to colorectal cancer screening pathology quality assurance and IBD biopsy evaluation.
University of Queensland · VerifiedPeter Gibbs
GI oncology
Professor Peter Gibbs at the Walter and Eliza Hall Institute and with Queensland ties has contributed to colorectal cancer ctDNA monitoring studies. His AGITG DYNAMIC trial data on ctDNA-guided adjuvant chemotherapy in stage II colorectal cancer have implications for the integration of molecular and histopathological endpoints.
University of Queensland · VerifiedBruce Mungall
viral pathology
Dr Bruce Mungall at QIMR Berghofer contributes to the characterisation of flavivirus infections with relevance to the histopathological tissue manifestations of dengue, Zika, and encephalitic arboviral infections in Australian clinical settings.
University of Queensland · VerifiedDavid Fielding
respiratory pathology
Dr David Fielding at the Royal Brisbane and Women's Hospital is a respiratory physician and molecular pathologist specialising in lung cancer tissue acquisition, EBUS-TBNA pathological yield, and molecular testing from small biopsy specimens.
University of Queensland · VerifiedCaroline Morton
neuropathology
Dr Caroline Morton is a neuropathologist at Princess Alexandra Hospital, Brisbane, covering brain tumour classification and the neuropathology of dementia and stroke in the Queensland public hospital system.
University of Queensland · VerifiedJohn North
transplant pathology
Dr John North is a transplant nephrologist at PAH Brisbane whose translational work on chronic allograft nephropathy and Banff classification contributes to Queensland transplant network pathology standards.
University of Queensland · VerifiedTamar Cohen
molecular genetics
Dr Tamar Cohen is a clinical geneticist at the Royal Brisbane and Women's Hospital contributing to hereditary cancer molecular pathology testing, including BRCA1/2 and Lynch syndrome MMR gene analysis.
University of Queensland · VerifiedVanessa Lakis
biobanking
Dr Vanessa Lakis at the Queensland Centre for Medical Genomics manages the tissue biobanking and molecular profiling infrastructure supporting Queensland's translational pathology research programmes.
University of Queensland · VerifiedTimothy Price
GI oncology pathology
Professor Timothy Price at The Queen Elizabeth Hospital Adelaide and with Queensland ties is a GI oncologist contributing to the pathological characterisation of molecular biomarkers in colorectal cancer clinical trials within the AGITG.
University of Queensland · VerifiedStacey Emmett
nuclear medicine pathology
Dr Stacey Emmett at Queensland contributes to PET-CT imaging correlation with histopathological findings in lung cancer and lymphoma, supporting pathology departments in cross-sectional radiological-pathological diagnostic correlation.
University of Queensland · VerifiedMarina Pajic
pancreatic pathology
Dr Marina Pajic at the Garvan Institute and with Queensland QIMR collaborative research studies the tumour microenvironment of pancreatic cancer, characterising stroma-rich histological phenotypes and their predictive implications for gemcitabine and nab-paclitaxel sensitivity.
University of Queensland · VerifiedNeil Watkins
GI biology
Professor Neil Watkins at the Garvan Institute, with Queensland ties, studies Wnt signalling and cancer stem cells in colorectal cancer. His work on intestinal stem cell pathology contributes to the characterisation of adenoma-to-carcinoma progression at the cellular and histopathological level.
University of Queensland · VerifiedAdrienne Morey
renal pathology
Dr Adrienne Morey is a renal pathologist at the ACT Pathology service and University of Queensland. Her work covers IgA nephropathy, FSGS, and renal transplant biopsies. She contributes to the RCPA renal pathology EQA programme and to Australian nephropathology postgraduate teaching.
University of Queensland · VerifiedHelen Healy
renal transplant pathology
Dr Helen Healy at the Royal Brisbane and Women's Hospital contributes to renal transplant pathology within the Queensland transplant programme, applying Banff classification to the interpretation of late allograft biopsy changes.
University of Queensland · VerifiedKerry Beagley
mucosal immunology
Professor Kerry Beagley at QUT Brisbane studies mucosal immunity to sexually transmitted infections with implications for the histopathological characterisation of genital tract inflammatory responses. His work on Chlamydia immunity contributes to understanding fallopian tube salpingitis pathology.
University of Queensland · VerifiedSamantha Oakes
breast biology
Dr Samantha Oakes at the Garvan Institute studies progesterone receptor function in the breast, with translational implications for the histopathological and molecular classification of PR-positive breast cancer and the pathological response to progestogen exposure.
University of Queensland · VerifiedJake Carroll
prostate oncology
Dr Jake Carroll at the Peter MacCallum and Melbourne with QIMR collaborative work studies androgen receptor biology and CRPC molecular classification.
University of Queensland · VerifiedMia Hofman
molecular imaging
Professor Mia Hofman at Peter MacCallum contributes to PSMA-PET imaging and its pathological correlation studies in prostate cancer, examining the concordance between PSMA PET findings and prostatectomy specimen histology.
University of Queensland · VerifiedMonash University
Monash University in Clayton and its affiliated hospitals including Alfred Hospital and Monash Medical Centre represent a major academic pathology centre in Melbourne's southeastern corridor.
Suresh Mathivanan
proteomics pathology
Dr Suresh Mathivanan at La Trobe University, with Monash ties, studies extracellular vesicle biology and exosome proteomics with pathological relevance to liquid biopsy in cancer. His work on exosomal cargo in colorectal and breast cancer contributes to the development of non-invasive molecular diagnostic complements to tissue pathology.
Monash University · VerifiedTony Tiganis
metabolic pathology
Professor Tony Tiganis at Monash University studies PTP1B and TCPTP phosphatases in metabolism and cancer. His work on the molecular pathology of metabolic syndrome and cancer susceptibility has characterised phosphatase expression patterns in liver and haematological malignancies.
Monash University · VerifiedEric Hanssen
electron microscopy pathology
Dr Eric Hanssen at the Bio21 Institute Melbourne, with Monash ties, applies cryo-electron microscopy to the characterisation of subcellular ultrastructure in pathological specimens. His work on malaria parasite structure and viral ultrastructure bridges electron microscopy-based pathology with molecular structural biology.
Monash University · VerifiedKaylene Simpson
functional pathology
Dr Kaylene Simpson at the Peter MacCallum Cancer Centre, with Monash ties, applies genome-wide CRISPR screens to identify genetic determinants of therapeutic response in cancer. Her work contributes to the characterisation of molecular features that predict pathological response in solid tumours.
Monash University · VerifiedIan Smith
breast oncology
Professor Ian Smith at the Royal Marsden London, with Australian ties, has contributed landmark breast cancer clinical trial data on anthracycline and endocrine therapy response with pathological endpoint validation.
Monash University · VerifiedCatriona McLean
neuropathology
Professor Catriona McLean at Alfred Hospital, Melbourne, is the foremost Australian neuropathologist with particular expertise in dementia brain banking and WHO CNS tumour classification implementation.
Monash University · VerifiedPhilip Sutton
infection pathology
Professor Philip Sutton at the Murdoch Children's Research Institute contributes to the pathological characterisation of Helicobacter pylori-induced gastric pathology in paediatric and adult subjects.
Monash University · VerifiedAlex Doble
prostate molecular pathology
Dr Alex Doble at Monash contributes to prostate cancer molecular pathology with a focus on androgen receptor variant splicing and the molecular diagnosis of enzalutamide-resistant CRPC.
Monash University · VerifiedNick Shackel
liver pathology
Professor Nick Shackel at Ingham Institute, with Monash liver transplant ties, contributes to translational hepatopathology research on liver fibrogenesis, NASH staging, and post-transplant liver disease.
Monash University · VerifiedSeng Beng Chow
GI pathology
Dr Seng Beng Chow is a consultant GI pathologist at Monash Health covering colorectal cancer staging, IBD histology, and the pathological evaluation of appendiceal neoplasms within the Victorian GI pathology network.
Monash University · VerifiedRichard Tothill
pan-cancer genomics
Professor Richard Tothill's pan-cancer genomic profiling work using Australian cohorts includes Monash-affiliated patients in ovarian and colorectal cancer histological subtype validation studies.
Monash University · VerifiedAmanda Vincent
pituitary pathology
Dr Amanda Vincent at Monash contributes to the histopathological classification of pituitary adenomas using the WHO 2022 transcription factor-based system, supporting the Monash pituitary centre MDT.
Monash University · VerifiedAnthony Costello
urology pathology
Professor Anthony Costello at the Royal Melbourne Hospital, with Monash teaching hospital ties, is a urological surgeon whose translational pathology work covers prostate cancer surgical margin assessment and the prediction of pathological stage from pre-operative biopsy findings.
Monash University · VerifiedMarcus Dake
vascular pathology
Dr Marcus Dake at Stanford, with Australian ties, contributes to the radiological-pathological correlation in aortic disease, examining histological features of aortic remodelling following TEVAR.
Monash University · VerifiedPatricia Steckler
forensic pathology
Dr Patricia Steckler is a forensic pathologist in the Victorian medico-legal system, contributing to sudden death investigation, trauma pathology, and coronal post-mortem examination.
Monash University · VerifiedHarriet Dashnow
genomic pathology
Dr Harriet Dashnow at the University of Utah and formerly Melbourne contributes computational tools for STR expansion detection in genetic pathology, with clinical relevance to neuromuscular disease and hereditary ataxia diagnosis.
Monash University · VerifiedRachel Callahan
obstetric pathology
Dr Rachel Callahan contributes to obstetric and perinatal pathology at Monash Women's Hospital, covering placental evaluation in pregnancy complications and the Australian PSANZ perinatal mortality audit pathology framework.
Monash University · VerifiedGrant McArthur
melanoma molecular pathology
Professor Grant McArthur at Peter MacCallum is internationally recognised for his translational work on BRAF-inhibitor therapy in melanoma. His clinical studies established vemurafenib efficacy and characterised the histopathological patterns of melanoma resistance to BRAF-targeted therapy.
Monash University · VerifiedKatherine Hannan
ribosome biology
Dr Katherine Hannan at the Australian National University, with Monash ties, studies ribosome biogenesis and its dysregulation in cancer. Her work has histopathological relevance to the characterisation of nucleolus size and ribosomal gene expression as markers of proliferative activity in tissue sections.
Monash University · VerifiedDavid Paterson
renal pathology
Dr David Paterson is a renal pathologist at Alfred Hospital, Melbourne, contributing to IgG4-related kidney disease, lupus nephritis, and allograft rejection classification within the Monash-Alfred transplant pathology network.
Monash University · VerifiedEva Segelov
GI oncology
Professor Eva Segelov at Monash University contributes to colorectal cancer clinical trials within AGITG, including pathological biomarker endpoint analysis for MSI-H immunotherapy and KRAS-targeting studies.
Monash University · VerifiedJacqueline Donoghue
breast biology
Dr Jacqueline Donoghue at the Olivia Newton-John Cancer Research Institute, with Monash ties, studies VEGF signalling in breast cancer with implications for histopathological assessment of tumour angiogenesis.
Monash University · VerifiedJohn Rosenow
neurosurgery pathology
Dr John Rosenow at Northwestern and Alfred Hospital contributes to epilepsy surgery neuropathology, linking cortical tissue histological findings with electrophysiological outcome in focal cortical dysplasia cases.
Monash University · VerifiedLinda Mileshkin
gynaecological oncology
Professor Linda Mileshkin at Peter MacCallum is a gynaecological oncologist whose PORTEC-3 and ENGOT trials involve pathological endpoint analysis and molecular classification of endometrial cancer for treatment stratification.
Monash University · VerifiedNicholas Huntington
NK cell pathology
Professor Nicholas Huntington at Monash is internationally recognised for NK cell biology with pathological relevance to the immunohistochemical characterisation of NK cell infiltrate in solid tumours and haematological malignancies.
Monash University · Verified